知乎

CVS removing decongestant from shelves after FDA panel says it's ineffective_我的网站

A |     北京時間週四上晝，WNBA常規賽好戲連場，其中飛翼主場迎戰節奏在較早時段開波。兩隊近期都陷入連敗泥潭，不過對比各自當前處境可看出飛翼的實力明顯在節奏之上，因此看好飛翼贏球止頹。
    
    　　今季強勢崛起的飛翼想以有利位置開啟季後賽征程，無奈最近一波三連敗讓她們在競爭形勢裡暫時落於被動，當務之急是贏球提振士氣。此番一大利好，飛翼今季主場對陣當下前八名之外的隊伍6戰全勝，當中半數場次淨勝至少15分。人手方面，內線核心謝絲嘉舒柏特上仗受傷，今仗缺陣；好在球隊今季頭兩次面對節奏時的整體發揮不俗，尤其是柏治布克絲均場斬獲28分，對方難以對其有效限制，期待她今仗再有精彩個人演出。

B |
    
    　　節奏在賽季早段有過不少驚喜，頭12場打出7勝5負；然而近20場慘遭3勝17負，並深陷九連敗，儼然撞上「新軍墻」無法自拔。    CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。必須指出，節奏近10場客場輸9場，其中6場淨負分差為雙位數。與此同時，節奏今季客場僅1場失分低於90分，也是其防守水平為全聯盟最差的一大體現。何況節奏今季已兩負飛翼，均場失分多達98.5分，兩場都淨負13分，彼此間實力存在明顯差距，前者此行可謂毫無勝算。

C | 陣容方面，比特妮史姬絲仍舊傷缺。

D |

Current article:http://g2yeru6.liangkuataosanxuanmiancen.sbs/list_rzq4az/80n.html

Published on:01:39:39